Cargando…
Taxifolin Alleviates DSS-Induced Ulcerative Colitis by Acting on Gut Microbiome to Produce Butyric Acid
Taxifolin is a bioflavonoid which has been used to treat Inflammatory Bowel Disease. However, taxifolin on DSS-induced colitis and gut health is still unclear. Here, we studied the effect of taxifolin on DSS-induced intestinal mucositis in mice. We measured the degree of intestinal mucosal injury an...
Autores principales: | Li, Wei, Zhang, Le, Xu, Qingbiao, Yang, Wenbo, Zhao, Jianan, Ren, Ying, Yu, Zhendong, Ma, Libao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912346/ https://www.ncbi.nlm.nih.gov/pubmed/35268045 http://dx.doi.org/10.3390/nu14051069 |
Ejemplares similares
-
Dietary Taxifolin Protects Against Dextran Sulfate Sodium-Induced Colitis via NF-κB Signaling, Enhancing Intestinal Barrier and Modulating Gut Microbiota
por: Hou, Jinxiu, et al.
Publicado: (2021) -
Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome
por: Satka, Stefan, et al.
Publicado: (2022) -
Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium
por: Zhang, Qianpeng, et al.
Publicado: (2016) -
Gut Protective Effect from D-Methionine or Butyric Acid against DSS and Carrageenan-Induced Ulcerative Colitis
por: Ikeda, Yuka, et al.
Publicado: (2023) -
Butyrate Treatment of DSS-Induced Ulcerative Colitis Affects the Hepatic Drug Metabolism in Mice
por: Jourova, Lenka, et al.
Publicado: (2022)